KAYBRAXO
LIVE

Serial Number

79452111

Owner

Novartis Pharma AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KAYBRAXO Trademark

Serial Number: 79452111

KAYBRAXO is a trademark filed by Novartis Pharma AG on April 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis Pharma AG (6 trademarks)

Lichtstrasse 35
Basel 4056 , CH

Entity Type: 25

Trademark Details

Filing Date

April 16, 2026

Registration Date

Not Registered

Published for Opposition

August 25, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2026 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2026 CNSA
ASSIGNED TO EXAMINER
Jul 17, 2026 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 16, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2026 COAR
APPLICATION FILING RECEIPT MAILED
Jun 30, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 30, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 18, 2026 REPR